vs
NACCO INDUSTRIES INC（NC）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是NACCO INDUSTRIES INC的2.0倍（$127.1M vs $62.8M），再鼎医药同比增速更快（17.1% vs -4.3%），过去两年再鼎医药的营收复合增速更高（20.8% vs 9.5%）
纳科工业是一家总部位于美国俄亥俄州克利夫兰的上市控股公司，核心业务聚焦采矿与自然资源领域，旗下划分煤炭开采、北美采矿、矿产管理三大业务板块。其中煤炭开采板块采用服务型商业模式，依据长期合约为发电企业及活性炭生产商运营露天煤矿。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
NC vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的2.0倍
$62.8M
营收增速更快
ZLAB
高出21.4%
-4.3%
两年增速更快
ZLAB
近两年复合增速
9.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.8M | $127.1M |
| 净利润 | $8.8M | — |
| 毛利率 | 22.8% | 51.0% |
| 营业利润率 | 17.5% | -54.6% |
| 净利率 | 14.1% | — |
| 营收同比 | -4.3% | 17.1% |
| 净利润同比 | 80.0% | — |
| 每股收益（稀释后） | $1.17 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NCZLAB
| Q1 26 | $62.8M | — | ||
| Q4 25 | $66.8M | $127.1M | ||
| Q3 25 | $76.6M | $115.4M | ||
| Q2 25 | $68.2M | $109.1M | ||
| Q1 25 | $65.6M | $105.7M | ||
| Q4 24 | $70.4M | $108.5M | ||
| Q3 24 | $61.7M | $101.8M | ||
| Q2 24 | $52.3M | $100.1M |
净利润NCZLAB
| Q1 26 | $8.8M | — | ||
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $13.3M | $-36.0M | ||
| Q2 25 | $3.3M | $-40.7M | ||
| Q1 25 | $4.9M | $-48.4M | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $15.6M | $-41.7M | ||
| Q2 24 | $6.0M | $-80.3M |
毛利率NCZLAB
| Q1 26 | 22.8% | — | ||
| Q4 25 | 18.0% | 51.0% | ||
| Q3 25 | 13.0% | 59.5% | ||
| Q2 25 | 10.0% | 60.6% | ||
| Q1 25 | 14.7% | 63.6% | ||
| Q4 24 | 12.0% | 61.5% | ||
| Q3 24 | 11.7% | 64.1% | ||
| Q2 24 | 13.4% | 64.9% |
营业利润率NCZLAB
| Q1 26 | 17.5% | — | ||
| Q4 25 | 11.3% | -54.6% | ||
| Q3 25 | 8.8% | -42.3% | ||
| Q2 25 | -0.1% | -50.3% | ||
| Q1 25 | 11.7% | -53.3% | ||
| Q4 24 | 5.5% | -62.6% | ||
| Q3 24 | 31.9% | -66.6% | ||
| Q2 24 | 14.1% | -76.0% |
净利率NCZLAB
| Q1 26 | 14.1% | — | ||
| Q4 25 | -5.8% | — | ||
| Q3 25 | 17.3% | -31.2% | ||
| Q2 25 | 4.8% | -37.3% | ||
| Q1 25 | 7.5% | -45.8% | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 25.4% | -40.9% | ||
| Q2 24 | 11.4% | -80.2% |
每股收益（稀释后）NCZLAB
| Q1 26 | $1.17 | — | ||
| Q4 25 | $-0.53 | $-0.05 | ||
| Q3 25 | $1.78 | $-0.03 | ||
| Q2 25 | $0.44 | $-0.04 | ||
| Q1 25 | $0.66 | $-0.04 | ||
| Q4 24 | $0.99 | $-0.09 | ||
| Q3 24 | $2.14 | $-0.04 | ||
| Q2 24 | $0.81 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $715.5M |
| 总资产 | — | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NCZLAB
| Q1 26 | — | — | ||
| Q4 25 | $49.7M | $689.6M | ||
| Q3 25 | $52.7M | $717.2M | ||
| Q2 25 | $49.4M | $732.2M | ||
| Q1 25 | $61.9M | $757.3M | ||
| Q4 24 | $72.8M | $779.7M | ||
| Q3 24 | $63.1M | $616.1M | ||
| Q2 24 | $62.4M | $630.0M |
总债务NCZLAB
| Q1 26 | — | — | ||
| Q4 25 | $100.8M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $99.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $29.0M | — |
股东权益NCZLAB
| Q1 26 | — | — | ||
| Q4 25 | $429.2M | $715.5M | ||
| Q3 25 | $426.4M | $759.9M | ||
| Q2 25 | $413.1M | $791.7M | ||
| Q1 25 | $409.1M | $810.8M | ||
| Q4 24 | $404.9M | $840.9M | ||
| Q3 24 | $397.3M | $667.7M | ||
| Q2 24 | $384.1M | $704.2M |
总资产NCZLAB
| Q1 26 | — | — | ||
| Q4 25 | $661.2M | $1.2B | ||
| Q3 25 | $637.6M | $1.2B | ||
| Q2 25 | $631.3M | $1.2B | ||
| Q1 25 | $634.2M | $1.2B | ||
| Q4 24 | $631.7M | $1.2B | ||
| Q3 24 | $597.4M | $985.3M | ||
| Q2 24 | $560.1M | $987.4M |
负债/权益比NCZLAB
| Q1 26 | — | — | ||
| Q4 25 | 0.23× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.08× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流NCZLAB
| Q1 26 | — | — | ||
| Q4 25 | $11.4M | $-26.0M | ||
| Q3 25 | $42.3M | $-32.0M | ||
| Q2 25 | $-7.8M | $-31.0M | ||
| Q1 25 | $5.0M | $-61.7M | ||
| Q4 24 | $25.2M | $-55.8M | ||
| Q3 24 | $2.8M | $-26.8M | ||
| Q2 24 | $4.1M | $-42.2M |
自由现金流NCZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | $-26.7M | ||
| Q3 25 | — | $-35.0M | ||
| Q2 25 | — | $-33.9M | ||
| Q1 25 | — | $-63.2M | ||
| Q4 24 | — | $-58.4M | ||
| Q3 24 | — | $-28.2M | ||
| Q2 24 | — | $-42.9M |
自由现金流率NCZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | -21.0% | ||
| Q3 25 | — | -30.4% | ||
| Q2 25 | — | -31.1% | ||
| Q1 25 | — | -59.9% | ||
| Q4 24 | — | -53.8% | ||
| Q3 24 | — | -27.7% | ||
| Q2 24 | — | -42.9% |
资本支出强度NCZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 0.7% |
现金转化率NCZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 3.19× | — | ||
| Q2 25 | -2.39× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 3.33× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | 0.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NC
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
